L. Jack

发表

Association of midlife blood pressure to late-life cognitive decline and brain morphology

C. DeCarli, B. Miller, P. Wolf, 1998, Neurology.

Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins.

B L Miller, P A Wolf, C. DeCarli, 1998, Stroke.

Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.

J. McClure, G. Swan, L. Jack, 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Mood, Side-effects and Smoking Outcomes Among Persons With and Without Probable Lifetime Depression Taking Varenicline

H. Javitz, J. McClure, G. Swan, 2009, Journal of General Internal Medicine.

Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective.

H. Javitz, G. Swan, L. Jack, 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Differential rates of relapse in subgroups of male and female smokers.

M. M. Ward, D. Carmelli, G. Swan, 1993, Journal of clinical epidemiology.

Financial burden of tobacco use: an employer's perspective.

H. Javitz, G. Swan, L. Jack, 2006, Clinics in occupational and environmental medicine.

The contribution of genetic influences to measures of lower-extremity function in older male twins.

P. Wolf, D. Carmelli, J. Guralnik, 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

Clinical trial participant characteristics and saliva and DNA metrics

J. McClure, G. Swan, A. Bergen, 2009, BMC medical research methodology.

Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.

J. McClure, G. Swan, L. Jack, 2009, Journal of substance abuse treatment.

A Tailoring Algorithm to Optimize Behavior Change

Janet Brigham, Harold S. Javitz, Ruth E. Krasnow, 2014, 2014 47th Hawaii International Conference on System Sciences.

Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.

H. Javitz, G. Swan, L. Jack, 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Subgroups of smokers with different success rates after treatment with fluoxetine for smoking cessation.

B. Spring, G. Swan, R. Niaura, 1999 .

Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

H. Feiler, J. Illes, D. Carmelli, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

Self-reported abstinence effects in the first month after smoking cessation.

M. M. Ward, G. Swan, L. Jack, 2001, Addictive behaviors.

Subgroups of smokers with different success rates after use of transdermal nicotine.

M. M. Ward, G. Swan, L. Jack, 1997, Addiction.

Abstinence effects as predictors of 28-day relapse in smokers.

M. M. Ward, G. Swan, L. Jack, 1996, Addictive behaviors.

Cardiovascular reactivity as a predictor of relapse in male and female smokers.

H S Javitz, M. M. Ward, H. Javitz, 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes

D. Hinds, H. Javitz, D. Conti, 2011, The Pharmacogenomics Journal.

Resequencing of Nicotinic Acetylcholine Receptor Genes and Association of Common and Rare Variants with the Fagerström Test for Nicotine Dependence

M. Kennemer, R. Stokowski, D. Ballinger, 2010, Neuropsychopharmacology.

Smoking outcome by psychiatric history after behavioral and varenicline treatment.

H. Javitz, J. McClure, G. Swan, 2010, Journal of substance abuse treatment.

Asthma Discordance in Twins Is Linked to Epigenetic Modifications of T Cells

G. Swan, Marco A Garcia, K. Nadeau, 2012, PLoS ONE.

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

H. Javitz, J. McClure, G. Swan, 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Differential genetic influence for components of memory in aging adult twins.

P. Wolf, D. Carmelli, G. Swan, 1999, Archives of neurology.

Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.

H. Javitz, J. McClure, G. Swan, 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Behavioral counseling and varenicline treatment for smoking cessation.

H. Javitz, J. McClure, G. Swan, 2010, American journal of preventive medicine.

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR

G. Swan, L. Jack, T. Mcafee, 2005, The Pharmacogenomics Journal.

Effectiveness of Bupropion Sustained Release for Smoking Cessation in a Health Care Setting: A Randomized Trial

H. Javitz, G. Swan, L. Jack, 2003 .

Predictors of brain morphology for the men of the NHLBI twin study.

C. DeCarli, P. Wolf, D. Carmelli, 1999, Stroke.

The Twin Research Registry at SRI International

Christina N. Lessov-Schlaggar, C. N. Lessov-Schlaggar, G. Swan, 2012, Twin Research and Human Genetics.

Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation

H. Javitz, J. McClure, G. Swan, 2011, Translational behavioral medicine.

Mood, Side-effects and Smoking Outcomes Among Persons With and Without Probable Lifetime Depression Taking Varenicline

H. Javitz, J. McClure, G. Swan, 2009, Journal of General Internal Medicine.

Heterogeneity in 12-month outcome among female and male smokers.

H. Javitz, G. Swan, L. Jack, 2004, Addiction.

Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.

H. Javitz, G. Swan, L. Jack, 2004, The American journal of managed care.

Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.

H. Javitz, G. Swan, L. Jack, 2004, Archives of internal medicine.

Outcomes from a patient-centered residential treatment plan for tobacco dependence.

G. Swan, L. Jack, J. Hodgkin, 2013, Mayo Clinic proceedings.

Adolescent smoking trajectories and nicotine dependence.

Judy A Andrews, Hyman Hops, Janet Brigham, 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Predictors of 12-Month Outcome in Smokers Who Received Bupropion Sustained-Release for Smoking Cessation

H. Javitz, J. McClure, G. Swan, 2008, CNS Drugs.

Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.

G. Swan, L. Jack, T. Mcafee, 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting.

G. Swan, L. Jack, T. Mcafee, 2003, Preventive medicine.

Lessons from an Online Stop-Smoking Intervention: Adaptations for Mobile Implementation

Janet Brigham, Harold S. Javitz, Ruth E. Krasnow, 2013, 2013 46th Hawaii International Conference on System Sciences.

Relationship of Family History Scores for Stroke and Hypertension to Quantitative Measures of White-Matter Hyperintensities and Stroke Volume in Elderly Males

C. DeCarli, P. Wolf, D. Carmelli, 2000, Neuroepidemiology.

Effect of smoking cessation and relapse on cardiovascular levels and reactivity

M. M. Ward, H. Javitz, G. Swan, 1994, Psychopharmacology.

Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.

H. Javitz, J. McClure, G. Swan, 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.

J. McClure, G. Swan, L. Jack, 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Ambulatory monitoring of heart rate and blood pressure during the first week after smoking cessation.

M. M. Ward, H. Javitz, G. Swan, 1995, American journal of hypertension.